Article
Crk and CrkL as Therapeutic Targets for Cancer Treatment
27 Mar 2021
Abstract excerpt
Crk and CrkL are cellular counterparts of the viral oncoprotein v-Crk. Crk and CrkL are overexpressed in many types of human cancer, correlating with poor prognosis. Furthermore, gene knockdown and knockout of Crk and CrkL in tumor cell lines suppress tumor cell functions, including cell proliferation, transformation, migration, invasion, epithelial-mesenchymal transition, resistance to chemotherapy drugs, and in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
